saw that ...didn't get the whole thing. put up the link if you can.
A man gains the ability to use the full extent of his brain's capabilities. A television adaptation of the 2011 film, 'Limitless'. With the help of a mysterious pill that enables the user to access 100 percent of his brain abilities, a struggling writer becomes a financial wizard, but it also puts him in a new world with lots of dangers. ;)
Classic soft bash. ....worried....difficult condition....other companies failures....burn rate....dilution...Basically all the major food groups for the soft basher diet.
I really don't care for this type of information gathering. Watching elevators, checking sign-in books etc, Even trying to get "insider " info from IR is usually fruitless anyway. And who's to say this kind of info is totally correct anyway, the girl who replied could be wrong. Next thing you know this guy will "deliver flowers " to research subjects to sneak a peek at their records.
Alzheimer's Disease R and D in the last 10 years has failed, simply removing the plaque burden doesn't seem to be the answer. By moving the "attack" up stream to a higher level of the pathological pathway-very complicated science- AVXL has had really great results...despite the low numbers showing greater efficacy than Standard of Care and Disease Modification - this could be a Major Breakthrough in AD. The light at the end of the tunnel. We are talking 5 mil patients in the USA and about 35mil world wide. A 65 Billion dollar market.
Not sure if you interpreted that correctly, by "initial clinical data" he could be referring to the data already released on the first 12 patients. Isn't the study double blinded?
Look all of us have waited a very long time for the NDA. We all need a well deserved breather. Quiet period for a while I guess. Monitor AVXL for a while , lots of posting. Interesting stock.
Similar results for Part B could see a 20-30 million share day. Many waiting on the side lines for those results. Momentum hasn't even started yet.
Not a cure, but a treatment. Maybe what happens is patients stay on A2-73+ for a few yrs, get a MRI and if the plaque "number" is low they get changed to A2-73 alone as maintenance therapy? I mean A2-73 alone should cost less than the combo pill.